Letter: PCSK9 inhibitor for liver transplant patients during the post-statin era? Authors' reply
- PMID: 36480715
- DOI: 10.1111/apt.17295
Letter: PCSK9 inhibitor for liver transplant patients during the post-statin era? Authors' reply
Comment on
-
Use of statins after liver transplantation is associated with improved survival: results of a nationwide study.Aliment Pharmacol Ther. 2022 Oct;56(7):1194-1204. doi: 10.1111/apt.17192. Epub 2022 Aug 18. Aliment Pharmacol Ther. 2022. PMID: 35979872 Free PMC article.
-
Letter: PCSK9 inhibitor for liver transplant patients during the post-statin era?Aliment Pharmacol Ther. 2023 Jan;57(1):185-186. doi: 10.1111/apt.17258. Aliment Pharmacol Ther. 2023. PMID: 36480716 No abstract available.
References
REFERENCES
-
- Wang J, Wu J, He Z, Xin H. Letter: PCSK9 inhibitor for liver transplant patients during the post-statin era? Aliment Pharmacol Ther. 2022; in press.
-
- Becchetti C, Dirchwolf M, Schropp J, Magini G, Müllhaupt B, Immer F, et al. Use of statins after liver transplantation is associated with improved survival: results of a nationwide study. Aliment Pharmacol Ther. 2022 Oct;56(7):1194-204.
-
- Jennings DL, Sultan L, Mingov J, Choe J, Latif F, Restaino S, et al. PCSK9 inhibitors safely and effectively lower LDL after heart transplantation: a systematic review and meta-analysis. Heart Fail Rev. 2022 Jun 10. https://doi.org/10.1007/s10741-022-10255-5
-
- Gracia-Sancho J, Russo L, García-Calderó H, García-Pagán JC, García-Cardeña G, Bosch J. Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver. Gut. 2011 Apr;60(4):517-24.
-
- Basiak M, Kosowski M, Cyrnek M, Bułdak Ł, Maligłówka M, Machnik G, et al. Pleiotropic effects of PCSK-9 inhibitors. Int J Mol Sci. 2021 Mar 19;22(6):3144.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical